Back to top
more

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Valic Co I Health Sciences Fd: (MF: VCHSX)

(MF) As of Jul 30, 2015 06:06 PM ET

 Add to portfolio

$27.62 USD

-0.07 (-0.25%)

Zacks MF Rank : 2 - Buy [?]   2      

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Latest Performance as of Jun 30, 2015

Total Return %* Percentile Rank Objective
YTD 20.17 15
3 months 5.40 25
6 months 20.17 15
1 Year 43.15 19
3 Year 36.14 25
5 Year 33.41 17
10 Year NA NA

* Annual for three years and beyond.

Zacks Premium Research for VCHSX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Buy 2
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 38.74
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 6/30/2015 730.17
%Turnover 6/30/2015 59.00

Risk

3 Year 5 Year 10 Year
Beta 0.86 0.87 NA
Alpha 19.52 16.78 NA
R Squared 0.31 0.51 NA
Std. Dev. 13.32 14.55 NA
Sharpe 2.79 2.38 NA

Sector / Country Weightings

As of 6/30/2015 % of Portfolio
Health 55.46
Finance 11.21
Services 9.76
Other 8.79
Industrial Cyclical 5.61
Retail Trade 5.52
Technology 3.02
Non-Durable 0.63

Portfolio Holdings

Top Equity Holdings
(As of 2/28/2015)
% of Portfolio Value (Mil$)
ALLERGAN INC 4.37 37.10
GILEAD SCIENCES INC 4.02 34.13
ALEXION PHARMACEUTICALS I 3.76 31.90
ACTAVIS PLC 3.52 29.83
VALEANT PHARMACEUTICALS 3.39 28.76
PHARMACYCLICS INC 3.37 28.59
MCKESSON CORP 3.33 28.29
AETNA INC 3.08 26.09
UNITEDHEALTH GROUP INC 2.96 25.12

Stock Holding % of Net Assets

As Of 2/28/2015
Total Issues 153
Avg. P/E 25.89
Avg. P/Book 5.19
Avg. EPS Growth 12.46
Avg. Market Value (Mil $) 45,386

Allocation

% of Portfolio
Large Growth 28.67
Large Value 0.00
Small Growth 30.97
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 12.68
Foreign Bond 0.00
High Yield Bond 0.00